We are continuing to liaise with NHS England (which can provide advice to ICBs on market entry issues) and PCSE to try to help reduce the overall timescales for the determination of applications. We have produced a guidance document with 10 key points to support applicants and their referees with their market entry applications. We [...]
The post Market Entry Applications – 10 Key Points Guidance appeared first on Community Pharmacy England.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Levemir InnoLet® (insulin detemir) 100units/ml solution for injection 3ml pre-filled disposable devices. MSN/2024/033 Tier 2 – medium impact Date of issue: 21st March 2024 Levemir® InnoLet® (insulin detemir) 100units/ml solution for injection 3ml pre-filled disposable devices are being discontinued with remaining [...]
The post Medicine Supply Notification: Levemir InnoLet® (insulin detemir) 100units/ml solution for injection 3ml pre-filled disposable devices appeared first on Community Pharmacy England.
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices MSN/2024/032 Tier 2 – medium impact Date of issue: 21st March 2024 Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices are being discontinued [...]
The post Medicine Supply Notification: Insulatard® InnoLet® (insulin isophane human) 100units/ml suspension for injection 3ml pre-filled disposable devices appeared first on Community Pharmacy England.
Class 4 Medicines Defect Information: Sodium Chloride Intravenous Infusion 0.9% Freeflex (Fresenius Kabi Limited) Drug alert number: EL (24)A/10 Date issued: 21 March 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Sodium Chloride Intravenous Infusion 0.9% Freeflex (Fresenius Kabi Limited) Company name: Fresenius Kabi [...]
The post MHRA Class 4 Medicines Notification: Sodium Chloride Intravenous Infusion 0.9% Freeflex (Fresenius Kabi Limited) appeared first on Community Pharmacy England.
The NHS Business Services Authority (NHSBSA) has emailed pharmacy owners today to say that the Pharmacy First IT system suppliers have resolved issues with the data they supplied to the Manage Your Service (MYS) portal for the February 2024 NHS Pharmacy First activity. NHS England and the Department of Health and Social Care have also [...]
The post Pharmacy First declaration data issue resolved appeared first on Community Pharmacy England.
Recent Comments